This Week at FDA: HHS considering new FDA posts, FDA approves slew of firsts, and more

The HHS is considering creating new FDA deputy commissioner roles focused on technology and drugs to increase administrative influence, while the FDA approved multiple first-of-their-kind treatments including targeted cancer drugs and a novel wearable device for dual glucose and ketone monitoring.

This Wire brief sits within Fusion42's coverage of Health.